Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oncolytics Biotech files IND for clinical trial of Reolysin in recurrent malignant glioma

March 12, 2002

Phase IIa trial of PCK-3145 in prostate cancer cleared by MCA

March 12, 2002

New combination treatment for advanced hepatocellular carcinoma is safe, beneficial

March 12, 2002

Patient enrollment target met in phase II/III trial of Onco TCS in relapsed aggressive NHL

March 12, 2002

Metvix PDT receives marketing authorization in Germany

March 12, 2002

Angiogenesis inhibitors described by researchers at Angiogene Pharmaceuticals

March 11, 2002

Rubitecan receives brand name Orathecin

March 11, 2002

Fast track designation for CCI-779 in renal cell carcinoma

March 11, 2002

AxCell Biosciences and Thomas Jefferson University to study protein implicated in cancer

March 11, 2002

Enchira develops protein-based cancer therapeutics

March 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...